To evaluate evidence of neutrophil activation in infants born to preeclamptic women and examine any association between degree of neutrophil activation and severity of pre-eclampsia.
INTRODUCTION
Pre-eclampsia is a syndrome characterized by hypertension and proteinuria appearing after the 20th week of pregnancy. 1 With hypertension, abnormalities in renal, hepatic, neural, and endothelial functioning may also be noted. Pre-eclampsia is one of the leading causes of maternal and perinatal morbidity and mortality. 2 The precise cause of this syndrome is not yet clear, but several theories have been suggested. 3 Many of these theories relate to the ischemic changes that take place in the placenta during trophoblast invasion in pre-eclamptic pregnancies.
During normal pregnancy, trophoblast invasion takes place in the decidual and myometrial segments of spiral arterioles, transforming the uteroplacental arterial bed into a low-resistance and high-flow system. In pre-eclampsia, these vascular changes take place only in the decidual segments of the spiral arterioles leading to chronic uteroplacental insufficiency and fetal hypoxia. 4 This chronic placental hypoxia leads to the release of substance(s) that may cause endothelial cell dysfunction. These substances include cytokines, 5 placental fragments, 6 free radicals, and reactive oxygen species. 7 Numerous studies have shown that endothelial cell activation/ injury occurs in pre-eclamptic women. [8] [9] [10] [11] [12] [13] Similar changes have been noted in umbilical vein endothelial cells in infants of pre-eclamptic women. 14, 15 Injured endothelial cells can initiate coagulation, platelet adhesion and activation, as well as vasoconstriction. 10, 16, 17 There is evidence of neutrophil activation in placental 18 and systemic circulations [19] [20] [21] [22] [23] [24] in women with pre-eclampsia. Activated neutrophils may release proteases and reactive oxygen species, 19, 21 which may cause vascular endothelial injury.
There is evidence that leukocyte activation occurs in the fetal circulation in severe pre-eclamptic pregnancies. 25 In this study, Mellembakken et al. looked at the surface expression of the integrins CD11a, CD11b, and CD11c on neutrophils and monocytes in infants of severely pre-eclamptic mothers and found an upregulation in the surface expression of CD11c on monocytes. Integrins are involved in the various steps of neutrophil/endothelial cell interaction. Upregulation of the integrins reflects an activated state of the neutrophil. Once neutrophils are activated, they participate in the various steps in the inflammatory sequence.
The purpose of the present study was to examine the surface expression of the integrins, CD18, CD11a, CD11b, and CD11c on neutrophils in infants born to women with mild, moderate, and severe pre-eclampsia. Our hypothesis was that upregulation of integrins on neutrophils occurs in fetal circulation in mild-tomoderate pre-eclamptic pregnancies as well as in severe cases.
METHODS
This study was reviewed and approved by the Institutional Review Board. Between January 2002 and November 2002, after obtaining informed consent, 49 pregnant women (22 with pre-eclampsia and 27 with uncomplicated pregnancies) were approached about their infant's enrollment into the study. Pregnancies with suspected fetal lethal anomalies and those associated with major factors likely to be precursors of fetal stress were excluded: maternal chorioamnionitis (intrapartum fever of above 100.41F, ruptured membranes >18 hours, foul-smelling amniotic fluid, uterine tenderness, elevated white blood cell (WBC) count, and elevated maternal C-reative protein (CRP)), maternal cardiopulmonary disease, and maternal diabetes. Women in active labor were also excluded from the study because active labor has been shown to be associated with fetal neutrophil activation. 26 Of the 49 women initially approached, 25 met eligibility criteria: 12 women were pre-eclamptic and 13 women had uncomplicated pregnancies and served as controls.
Pre-eclampsia was defined by the presence of hypertension after 20 weeks of gestation: (1) Systolic blood pressure >140 mmHg or diastolic blood pressure >90 mmHg, on at least two occasions at least 4 hours apart and (2) the presence of proteinuria (>0.3 g in a 24-hour urine collection or the presence of >1 þ proteinuria on urinary dipstick). Severe pre-eclampsia was defined by the presence of severe hypertension (systolic blood pressure >160 mmHg or diastolic blood pressure >110 mmHg) in association with proteinuria (>5 g in 24 hours).
Staining and Flow Cytometric Analysis
Using sterile technique, umbilical venous blood was collected at the time of delivery in ethylenediaminotetra-acetate (EDTA) Vacutainer tubes (Becton Dickinson). Cord blood samples were tested by direct immunofluorescence staining of whole blood using fluorochromeconjugated monoclonal antibodies. Monoclonal antibodies against neutrophil surface markers conjugated with fluorochromes (fluorescein isothiocyanate (FITC) for CD18 and PE for CD11a, CD11b, and CD11c) used for flow cytometry were purchased from BD Biosciences. Anti-mouse IgG 1 conjugated with both PE and FITC was used as isotype control. Blood samples were stored at room temperature until they were ready for staining and lysing. This was accomplished within 6 hours of obtaining cord blood specimens. All flow cytometric studies were performed on a BD FACSCalibur TM instrument. Compensation and PMT voltages were standardized before each run using Calibrite TM beads (BD). For the procedure, 10 ml of antibody to fluorochrome-conjugated antibody was added to 100 ml of whole blood (cord blood) in a 12 Â 75 mm 2 tube. The specimen was vortexed gently and then incubated in the dark for 15 minutes at room temperature (20 to 251C). Then 2 cm 3 of 1 Â FACS lysing solution was added and the specimen was gently vortexed and incubated in the dark at room temperature for another 10 minutes. The specimen was centrifuged at 500 Â g for 5 minutes. After removing the supernatant, 2 to 3 cm 3 of wash buffer solution was added and the specimen was again centrifuged for 5 minutes after which the supernatant was removed. Then 0.5 cm 3 of 1X paraformaldehyde was added to the pellets. The specimens were then stored between 2 and 81C, prior to analysis by flow cytometry. The specimens were tested by quantitative flow cytometry. The intensity levels for all fluorescent markers was standardized for each run using Calibrite beads (BD Biosciences). The intensity of the mean channel fluorescence (MCF) for PE conjugated anti-CD11a, anti-CD11b, and anti-CD11c binding to neutrophils was determined by comparing sample MCF of four levels of calibrated beads containing a known number of flourochrome molecules per bead (Quantibrite Beads, BD Biosciences). Analysis was performed using the quantitative calibration option of CellQest Software (BD Biosciences).
Statistical Analysis
Descriptive statistics were calculated on all infant and maternal characteristics, as well as MCF values. Study and control groups were compared using the Fisher's exact test for categorical variables and the MannÀWhitney U-test for continuous variables. A p-value of <0.05 was considered statistically significant for all comparisons.
RESULTS
Cord blood was analyzed from 20 infants in the pre-eclamptic and 19 infants in the control group. In the pre-eclamptic group, seven pregnancies resulted in singleton, two in twin, and three in triplet births. In the control group, nine pregnancies resulted in singleton, two in twin, and two in triplet births. Tables 1 and 2 summarize the maternal and infant characteristics of the pre-eclamptic and control groups. There were no significant differences between the pre-eclamptic and control groups with respect to maternal age, race, group B streptococcus (GBS) status, steroid use prior to delivery, gestational age, and birth weight. The mean gestational age for infants in the pre-eclamptic group was 32.7±3.9 and 34.0±5.6 weeks for the control group (p ¼ 0.833). The mean birth weight for the infants in the pre-eclamptic group (1776±1079) was lower compared to the control group (2393±1418), but the difference was not significant (p ¼ 0.169).
Neutrophil Surface Expression of Integrins
There were statistically significant differences in the expression of all of the neutrophil surface adhesion molecules between pre-eclmaptic and control groups. The infants born to pre-eclmaptic women demonstrated significant upregulation of CD18, CD11a, CD11b, and CD11c (Table 3) .
DISCUSSION
Pre-eclamptic pregnancies may be complicated by in utero growth restriction and premature delivery, which may increase neonatal morbidity and mortality. 27, 28 The factor(s) responsible for in utero growth restriction are thought to be related to impaired uteroplacental and fetoplacental circulations. 29 There is strong evidence that maternal endothelial cell dysfunction plays a central role in the pathogenesis of this disorder. 30 Neutrophil activation in maternal circulation contributes to the vascular injury in placental and systemic circulations. 31, 32 Normal endothelium is nonthrombogenic and prevents the formation of any clots in the circulation. 33 It also plays an important role in regulation of vascular tone. 34 Injured endothelium can activate clotting mechanism by both intrinsic and extrinsic pathways. 35 In preeclampsia, there is an imbalance between vasoconstriction factors (e.g. thromboxane A2) and vasodilation factors (e.g. nitric oxide and prostacyclin) leading to increased vasoconstriction. 36 These vascular changes in the placental circulation contribute to the chronic uteroplacental insufficiency characteristic of this disorder.
The oxidative stress and hypoxia in the fetoplacental circulation associated with pre-eclampsia may induce the release of chemokines that may activate neutrophils. 19, 20 There is evidence of neutrophil activation in the fetal circulation in pre-eclamptic pregnancies. 25 Activated neutrophils have the ability to bind to the surface of endothelial cells, which is the first step in the inflammatory sequence. Activated neutrophils release proteases and reactive oxygen species that can lead to endothelial cell injury, which may then contribute to the adverse circulatory effects in the fetal circulation. 19 Mellembakken et al. have studied the role of leukocyte activation in the fetal circulation in pre-eclamptic pregnancies. They looked at the expression of membrane-bound surface adhesion molecules in cord blood neutrophils and monocytes in infants of severely pre-eclamptic mothers. Of the three integrin molecules (CD11a, CD11b, and CD11c) studied, they found an upregulation of only CD11c on the monocytes in these infants. 18 In the present study, we had hypothesized that neutrophil activation occurs in the fetal circulation in all pre-eclamptic pregnancies, ranging from mild to severe pre-eclampsia. This hypothesis was supported in that study results demonstrated a statistically significant increase in the expression of the four integrin molecules in the pre-eclamptic group regardless of severity. This suggests that there is activation of neutrophils in the fetal circulation in pre-eclamptic pregnancies. The study also revealed that the expression of particular surface adhesion molecules, CD18 and CD11a, tends to be increased in severe pre-eclamptic pregnancies (Table 4 ). The observed upregulation suggests that in pre-eclampsia the neutrophils in the fetalcirculation are in an activated state. Activated neutrophils may adhere to the endothelium and release proteases and reactive oxygen species leading to endothelial dysfunction and increased vasoreactivity. Also, inflammatory mediators released by activated neutrophils may further activate endothelial cells and leukocytes, which may lead to a vicious cycle of neutrophil activation in fetuses of pre-eclamptic women. This cycle of activation may contribute to fetoplacental insufficiency and intrauterine growth restriction, as well as other factors associated with perinatal morbidity and mortality often noted in pre-eclampsia. Since we excluded pregnancies that might be associated with fetal stress, we do not know if a similar or different mechanism in these pregnancies might cause neutrophil activation. It is quite possible that the neutrophil activation that was observed in our study, could be a generalized response to impaired uteroplacental circulation noted in pre-eclampsia. This is a preliminary study that may lead to future studies that could better elucidate the exact pathogenetic mechanism of neutrophil activation in the affected fetus of pre-eclamptic pregnancy and any relationship with adverse fetal outcome. At this stage, these preliminary findings do not bear on clinical practice, but lay the groundwork for future research that may better inform clinical practice and the management of these infants.
